Sowell Financial Services’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $615K | Buy |
4,893
+107
| +2% | +$13.4K | 0.03% | 554 |
|
|
2025
Q1 | $529K | Buy |
+4,786
| New | +$529K | 0.02% | 569 |
|
|
2024
Q3 | – | Sell |
-10,914
| Closed | -$1.5M | – | 569 |
|
|
2024
Q2 | $1.5M | Sell |
10,914
-2
| -0% | -$275 | 0.07% | 271 |
|
|
2024
Q1 | $1.51M | Buy |
+10,916
| New | +$1.51M | 0.07% | 279 |
|
|
2021
Q2 | – | Sell |
-1,554
| Closed | -$139K | – | 1932 |
|
|
2021
Q1 | $139K | Sell |
1,554
-99
| -6% | -$8.86K | ﹤0.01% | 1225 |
|
|
2020
Q4 | $158K | Buy |
1,653
+182
| +12% | +$17.4K | 0.01% | 950 |
|
|
2020
Q3 | $141K | Sell |
1,471
-419
| -22% | -$40.2K | 0.01% | 857 |
|
|
2020
Q2 | $231K | Buy |
1,890
+1,014
| +116% | +$124K | 0.01% | 670 |
|
|
2020
Q1 | $76K | Buy |
876
+63
| +8% | +$5.47K | 0.01% | 921 |
|
|
2019
Q4 | $87K | Buy |
813
+659
| +428% | +$70.5K | 0.01% | 962 |
|
|
2019
Q3 | $14K | Buy |
+154
| New | +$14K | ﹤0.01% | 1415 |
|